Clonal thrombocytosis (CT) associated with my eloproliferative disorders (M
PD) is believed to be secondary to autonomous unregulated platelet producti
on. Secondary or reactive thrombocytosis (RT) can be observed in a number o
f clinical circumstances and may be related to persistent production of som
e thrombopoietic factors acting on megakaryocytes (MK). The goal of this st
udy is to assess the serum concentrations of these cytokines in control sub
jects and patients with MPD associated with thrombocythemia, RT, and autoim
mune thrombocytopenic purpura (ATP). Eleven patients with MPD, five with ch
ronic myeloid leukemia (CML), three with polycythemia vera (PCV), two with
essential thrombocythemia (ET), one with myelofibrosis, 15 with RT, eight w
ith ATP, and 12 healthy volunteers were enrolled in the study. Serum interl
eukin (IL)-1 beta, IL-6, tumor necrosis factor-alpha (TNF), fibronectin, in
tracellular adhesion molecule-1 (ICAM-1), and thrombomodulin (TM) were meas
ured in these groups.
Interleukin-1 beta, IL-6, and TNF levels were high in patients with RT and
ATP, suggesting that these cytokines act on early uncommitted progenitors,
promoting commitment along the MK lineage and leading to thrombocytosis or
compensation for thrombocytopenia. TM was significantly increased in patien
ts with MPD compared to all other groups, probably indicating the presence
of subclinical endothelial damage. Fibronectin levels were high in MPD and
RT patients. This finding can be secondary to high platelet turnover in the
se patients. We found that ICAM-1 levels were high in patients with clonal
thrombocytosis. ICAM-1 can be one of the factors initiating the events ulti
mately leading to clonal thrombocytosis. Thrombocythemia associated with MP
D is an autonomous phenomenon not regulated by cytokines.